Back to MW MARSHALL WACE, LLP

RNACRNAC
8 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CARTESIAN THERAPEUTICS INC

MARSHALL WACE, LLP holds 232,919 shares of RNAC (CARTESIAN THERAPEUTICS INC), worth $2.4M as of 2026-Q2. The position was decreased (-7.3% shares). RNAC represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$2.4M

Current Shares

232,919

Total Value Change

+$1.6M

Total Shares Change

+202,881

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
232,919
-7.3%
$2.4M0.0%$10.42
0
2026-Q1
Increased
251,115
+41.0%
$1.5M0.0%$7.48
34
2025-Q4
Increased
178,140
+110.1%
$1.3M0.0%$6.94
41
2025-Q3
Increased
84,806
+2.6%
$866,7180.0%$9.85
25
2025-Q2
Increased
82,630
+114.0%
$858,5260.0%$10.68
40
2025-Q1
New
38,605
-
$508,8140.0%$14.54
33
2024-Q3
Exited
0
-100.0%
$00.0%$17.00
0
2024-Q2
New
30,038
-
$811,3260.0%$27.01
34

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used